Figure 3.
Figure 3. Molecular mechanism of HIF-1α protein stabilization by CuCl2. (A) Hep3B hepatoma reporter cells (subline HRB5) were treated with or without 100 μM CuCl2 for 24 hours in the presence or absence of the indicated kinase inhibitors under normoxic conditions. Shown are mean induction factors of luciferase activity ± SD of n = 3 independent experiments. (B) Hep3B cells were kept under hypoxic conditions in the presence or absence of 150 μM CuCl2 before the addition of 20 μM cycloheximide (CHX) to block translation. Following reoxygenation for the indicated time periods, HIF-1α levels were determined by immunoblotting as in Figure 2. Subsequent detection of β-actin served as control for equal loading.

Molecular mechanism of HIF-1α protein stabilization by CuCl2. (A) Hep3B hepatoma reporter cells (subline HRB5) were treated with or without 100 μM CuCl2 for 24 hours in the presence or absence of the indicated kinase inhibitors under normoxic conditions. Shown are mean induction factors of luciferase activity ± SD of n = 3 independent experiments. (B) Hep3B cells were kept under hypoxic conditions in the presence or absence of 150 μM CuCl2 before the addition of 20 μM cycloheximide (CHX) to block translation. Following reoxygenation for the indicated time periods, HIF-1α levels were determined by immunoblotting as in Figure 2. Subsequent detection of β-actin served as control for equal loading.

Close Modal

or Create an Account

Close Modal
Close Modal